Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
204,797,543
-
Share change
-
-8,261,572
-
Total reported value
-
$8,334,355,321
-
Put/Call ratio
-
64%
-
Price per share
-
$40.55
-
Number of holders
-
707
-
Value change
-
-$334,382,915
-
Number of buys
-
324
-
Number of sells
-
289
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q1 2016
As of 31 Mar 2016 GLAXOSMITHKLINE PLC - ADR (GSK) had 707 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 204,797,543 shares of stock of the company.
Largest 10 holders included FMR LLC, Fisher Asset Management, LLC, WELLS FARGO & COMPANY/MN, JPMORGAN CHASE & CO, STATE STREET CORP, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, Bank of New York Mellon Corp, and FEDERATED INVESTORS INC /PA/.
This table shows 708 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.